One Month Wegovy Results: What Actually Happens in the First Four Weeks

The biggest misconception: slow early results mean the medicine isn't working

The most common worry people bring to our prescribers after a first month on Wegovy is that a modest number on the scales means something has gone wrong. It hasn't. At 0.25 mg, Wegovy is doing exactly what it was designed to do at this stage: letting your body acclimatise rather than driving aggressive weight loss. The dose is titrated upward roughly every four weeks (from 0.25 mg to 0.5 mg, then 1.0 mg, 1.7 mg, and eventually the 2.4 mg maintenance dose) with the significant appetite suppression emerging over that escalation period. Judging Wegovy by its one-month results is a little like judging a long-haul flight by the taxi to the airport.

What does happen in month one is real. Appetite shifts early for many people: portions feel smaller, high-fat foods become less appealing, and snacking often drops without a conscious effort. Some people notice a 1–2 kg reduction in the first fortnight alone, partly from lower calorie intake and partly from the fluid changes that come with eating less. A practical habit worth building now: take a waist measurement on the same morning each week, before breakfast. The tape measure often moves before the scale does, and tracking it takes under a minute.

People who see very little change in week one to two sometimes assume the pen is faulty or the dose is wrong. In almost all cases, neither is true, the medicine is establishing itself and the appetite signal arrives gradually. If you're genuinely concerned, that's a question for your prescriber, not a reason to increase the dose early.

What the trial evidence actually says about early Wegovy results

The STEP 1 trial followed adults with obesity on 2.4 mg semaglutide for 68 weeks. Average weight loss was around 15%, but that figure accumulated across the full titration schedule, not in the opening month. Early-phase data from the STEP programme consistently showed that participants lost roughly 2–4% of body weight in the first four to eight weeks combined, respectable, but a fraction of the eventual result. By month three the curve steepens noticeably as participants reach higher doses.

This matters for managing expectations. A person starting at 100 kg might see a 2–3 kg reduction by the end of month one. That's meaningful (it's not a rounding error) but it's the foundation, not the building. The NHS medicines page for semaglutide notes that weight loss with Wegovy continues over many months, and that treatment is intended as a long-term programme alongside a reduced-calorie diet and increased physical activity. There's more detail on how the timeline unfolds in our three-month Wegovy results and six-month results guides.

One thing the trial data also shows: people who made meaningful lifestyle changes alongside treatment lost more weight than those who didn't. The medicine reduces appetite; it can't substitute for movement and protein-adequate eating.

Side effects in the first four weeks and how to approach them

Nausea is the most commonly reported side effect in month one and is directly tied to the dose-escalation design. At 0.25 mg the gastric-emptying effect is present but mild; for most people the nausea is light and short-lived, often hitting in the first day or two after each injection and fading before the next dose. Vomiting is less common but possible, particularly if meals are large or fatty. Loose stools, constipation and reflux are also reported frequently in the early weeks.

None of this is a reason to stop, in most cases, and titrating slowly is specifically designed to keep side effects manageable. Eating smaller meals more often, staying well hydrated, and avoiding rich food on injection day helps considerably. If side effects feel severe or persistent, speak with your prescriber rather than adjusting timing or dose independently, the Patient Information Leaflet covers this in detail and should be your first reference, alongside your clinical team.

For context on what to expect further down the line, how long Wegovy takes to work covers the fuller picture from start through to steady state. And if you're weighing up semaglutide alongside other options, our treatment overview outlines what is currently licensed for weight management in the UK.

Realistic one-month benchmarks and when to review

There's no single figure that confirms month one has gone well, because starting weight, dose response, lifestyle changes and whether you're experiencing significant GI symptoms all affect the number. Broadly: a 1–4 kg reduction over four weeks is consistent with what the evidence suggests. Some people see more; a small number see less, particularly if nausea has made eating erratically difficult. Neither extreme is cause for alarm at this stage.

What the first month is for: establishing the habit of weekly injections, identifying which foods sit well and which don't, and beginning to notice appetite changes. These are the signals that the medicine is doing its job, even when the scale moves slowly. Our two-month results guide covers what typically changes as the first dose increase takes effect.

If you're still working out whether Wegovy is right for you, our full Wegovy guide covers the licence, the clinical evidence and the eligibility criteria in detail. For a sense of what private treatment costs and what's included, the Wegovy cost page sets out the honest picture. When you're ready to speak with a prescriber, you can check your eligibility through a free consultation, reviewed the same day by a real clinician, not software.